New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 21, 2014
07:37 EDTEWEdwards Lifesciences price target raised to $96 from $86 at Canaccord
Canaccord raised its price target on Edwards Lifesciences (EW) to $96 based on the worldwide patent litigation settlement with Medtronic (MDT). The firm believes the agreement removes an expensive distraction for the business and retains the goodwill of physicians. Shares are Buy rated.
News For EW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
19:16 EDTEWOn The Fly: After Hours Movers
Subscribe for More Information
16:19 EDTEWEdwards Lifesciences sees Q2 EPS $1.00-$1.10, consensus $1.05
Subscribe for More Information
16:18 EDTEWEdwards Lifesciences narrows FY15 EPS view to $4.10-$4.30, consensus $4.21
Subscribe for More Information
16:17 EDTEWEdwards Lifesciences reports Q1 EPS $1.12, consensus $1.04
Subscribe for More Information
15:00 EDTEWNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use